Αρχική World News New Areolar Incision Technique Leaves Almost No Scars for Breast Cancer Surgery...

New Areolar Incision Technique Leaves Almost No Scars for Breast Cancer Surgery Patients

Unsightly incisions are often a huge problem for women’s self-esteem after a breast cancer surgery. No longer having breasts that look like they used to tends to make women feel unlike themselves and less than feminine, and the issue can persist for years. But now a new type of incision may lead to decreased scarring for many of those patients, which can help them regain confidence more quickly and feel whole again.

Generally, when someone has surgery for breast cancer, the surgeon makes an incision straight across the breast horizontally to remove the affected tissue. But just because that’s the way the incision has always been done doesn’t mean it’s the right way or the best way. And recently, a team of researchers has discovered a way that they believe it can be done better.

Photo: Adobe Stock/a3701027

The areolar incision technique the team came up with involves cutting at the edge of the areola instead of straight across the breast when performing a mastectomy or lumpectomy. The scarring is easily disguised because of the natural color separation between the areola and the rest of the breast in that spot. This technique is emerging as an alternative that drastically reduces scarring and does not increase the risk to the patient.

The research team, from the Ewha Woman’s University Mokdong Hospital, conducted a study of 61 breast cancer patients who underwent surgery between December 2018 and February 2020 at that hospital. 41 had surgery with the areolar incision, while 20 had standard horizontal incisions. They compared the scarring results of the two groups as well as the risks involved with each.

Photo: Adobe Stock/Peter Atkins

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

The study results showed that the areolar incision left next to no scarring, and it did not appear to increase any safety risks involved with the surgery. The risk of complications and the amount of dermal necrosis were not elevated in the areolar incision patients.

“If the areolar incision technique is implemented together with indocyanine green angiography, which observes the blood circulation of the skin for about three minutes after injecting a contrast medium, it minimizes the risk of complications while leaving almost no visible scars,” says Professor Woo Kyung-jae, a member of the research team.

Photo: Adobe Stock/Rabizo Anatolii

This technique is still very new and not practiced by many surgeons, but we have hope based on these initial study results that they will soon be the standard in hospitals around the world.

If you’re interested in this type of incision, please ask your surgeon about it—even if he or she has never heard of it and won’t perform it, asking for it is still a great way to get the word out and to prompt more surgeons to do their research and try something new that may improve the lives of their patients.

Science and medicine have come a long way, but thank goodness they aren’t stopping now! You never know when you’ll find a better way to do something just around the corner.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source


Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...